Investments
63Portfolio Exits
9About Triathlon Medical Venture Partners
Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. Triathlon provides equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs. Triathlon is geographically focused on early stage opportunities in the Midwest but will also invest in later stage companies nationwide. The firm is headquartered in Cincinnati, with offices and partners in Indianapolis, Louisville and St. Louis. Triathlon invests from $0.5 to $3 million in the initial round and up to $7 million total per company in subsequent rounds. Triathlon will lead most early-stage investments and fewer of the later stage investment rounds.
Want to inform investors similar to Triathlon Medical Venture Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Triathlon Medical Venture Partners Investments
63 Investments
Triathlon Medical Venture Partners has made 63 investments. Their latest investment was in Eccrine Systems as part of their Series B - II on October 10, 2019.
Triathlon Medical Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/18/2019 | Series B - II | Eccrine Systems | $1.87M | Yes | 1 | |
10/25/2018 | Series B | Enable Injections | $30.67M | Yes | 3 | |
3/17/2017 | Corporate Minority | Aerpio Pharmaceuticals | $40M | Yes | 2 | |
5/12/2015 | Series B - III | |||||
1/13/2015 | Series C |
Date | 10/18/2019 | 10/25/2018 | 3/17/2017 | 5/12/2015 | 1/13/2015 |
|---|---|---|---|---|---|
Round | Series B - II | Series B | Corporate Minority | Series B - III | Series C |
Company | Eccrine Systems | Enable Injections | Aerpio Pharmaceuticals | ||
Amount | $1.87M | $30.67M | $40M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 1 | 3 | 2 |
Triathlon Medical Venture Partners Portfolio Exits
9 Portfolio Exits
Triathlon Medical Venture Partners has 9 portfolio exits. Their latest portfolio exit was Eccrine Systems on May 04, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/4/2022 | Asset Sale | 2 | |||
Date | 5/4/2022 | ||||
|---|---|---|---|---|---|
Exit | Asset Sale | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Triathlon Medical Venture Partners Team
6 Team Members
Triathlon Medical Venture Partners has 6 team members, including current Managing Partner, Carolyn Bates.
Name | Work History | Title | Status |
|---|---|---|---|
Carolyn Bates | Managing Partner | Current | |
Name | Carolyn Bates | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Managing Partner | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
